Noah Medical

Noah Medical's Galaxy System is a navigated robotic bronchoscopy platform. It combines TiLT+ technology (integrated tomosynthesis and augmented fluoroscopy) with a single-use disposable bronchoscope, and it is used for minimally invasive lung biopsy. It sells to hospitals and interventional pulmonologists and thoracic surgeons. The company received FDA clearance in March 2023, raised a $150M Series B led by SoftBank Vision Fund and Prosperity7 in April 2023, and performed its first US commercial procedure in May 2023. PitchBook lists about 309 employees in 2026 and a later Series B1 of $230M, which I could not confirm from a primary source.